Whirling Platelets Away for Transfusion
- PMID: 30053423
- PMCID: PMC6487281
- DOI: 10.1016/j.cell.2018.07.018
Whirling Platelets Away for Transfusion
Abstract
With a growing demand for platelet transfusions, large-scale ex vivo platelet production would alleviate the reliance on donors. Now, Ito et al. report that turbulence is an important physical regulator of platelet generation in vivo and can be exploited in a bioreactor to enable clinical scale production of functional platelets starting from human iPSCs.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment on
-
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.Cell. 2018 Jul 26;174(3):636-648.e18. doi: 10.1016/j.cell.2018.06.011. Epub 2018 Jul 12. Cell. 2018. PMID: 30017246
References
-
- Avanzi MP, and Mitchell WB (2014). Ex vivo production of platelets from stem cells. Br. J. Haematol. 165, 237–247. - PubMed
-
- Fong H, Mosoyan G, Patel A, Hoffman R, Tong J, and Iancu-Rubin C (2016). Preclinical Development of a Cryopreservable Megakaryocyte Cell Product from Cord Blood Derived Hematopoietic Stem Cells. Blood 128, 3859.
-
- Ito Y, Nakamura S, Tomohiro S, Naoshi S, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, et al. (2018). Turbulence activates platelet biogenesis to enable clinical scale manufacturing from human iPS cells. Cell 174, this issue, 636–648. - PubMed
-
- Kumar A, Mhaskar R, Grossman BJ, Kaufman RM, Tobian AA, Kleinman S, Gernsheimer T, Tinmouth AT, and Djulbegovic B; AABB Platelet Transfusion Guidelines Panel (2015). Platelet transfusion: a systematic review of the clinical evidence. Transfusion 55, 1116–1127, quiz 1115. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
